R Sánchez-Sánchez,
A Huertas-López… - Antimicrobial Agents …, 2024 - journals.asm.org
Drug development for congenital toxoplasmosis is challenging since first-line therapy has a
high rate of adverse effects and exhibits suboptimal efficacy. Bumped kinase inhibitors …